Thomas Yeung

Thomas Yeung

CFA, InvestorPlace Markets Analyst

Expertise: Fundamental Analysis, Quant-Based Investing, Tax Analysis

Education: BA, Economics, Princeton University

Awards & Accomplishments: CFA Charterholder, IRS Enrolled Agent

Thomas Yeung, CFA, is a Market Analyst at InvestorPlace.com, where he helps investors navigate the world of finance with one of the most powerful tools available: knowledge. Tom brings over a decade of experience in company, commodity and industry analysis.

He is the current editor of the Omnia Portfolios, the highest-tier subscription at InvestorPlace and the former editor of Tom Yeung’s Profit & Protection, a free e-letter about investing to profit in good times and protecting gains during the bad.

Tom started his investment career at Harding Loevner, a $40 billion asset management firm. Today, he works with InvestorPlace.com to help individuals and families identify great investments.

Tom holds a BA in Economics from Princeton University, where he graduated with high honors. He is a CFA® Charterholder and also a FINRA Registered Investment Adviser.

Recent Articles

Yes, Wall Street, Reddit’s #Silversqueeze Can Send Silver to $300

By Thomas Yeung, CFA, InvestorPlace Markets Analyst

Could the 15% rise in silver be just the start of more? Here's why investors and Wall Street needs to be careful of #silversqueeze.

4 Marijuana Stocks Set for Another Big Increase

By Thomas Yeung, CFA, InvestorPlace Markets Analyst

Marijuana stocks have been on a tear since the 2020 elections. With legalization possibly on the way, here are four stocks that could soar.

Reddit’s r/WallStreetBets Just Took Down a Hedge Fund. You’ll Love What Comes Next.

By Thomas Yeung, CFA, InvestorPlace Markets Analyst

This week, users on Reddit sent Melvin Capital into receivership on a GME stock bet gone bad. The fallout will be even weirder.

Novavax Vaccine’s Phase 3 Win Is Sending NVAX Stock to $350

By Thomas Yeung, CFA, InvestorPlace Markets Analyst

Novavax, an unlikely vaccine maker, lands another triumph for humankind and NVAX stock looks poised to keep soaring.

Redditors Are Betting on a $600 Ligand Stock Short Squeeze

By Thomas Yeung, CFA, InvestorPlace Markets Analyst

LGND stock is now the most-shorted stock available to Robinhood traders. Here's why investors should tread lightly going forward.

Load More